Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Canadian national survey of perinatal HIV infection 1991-1992. Canadian Paediatric AIDS Research Group (CPAR).
Duff FP, King SM, Lapointe N, Read S, Forbes J, Allen U. Duff FP, et al. Can J Public Health. 1994 Jul-Aug;85(4):239-43. Can J Public Health. 1994. PMID: 7987745
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group. Torriani FJ, et al. Among authors: duff f. N Engl J Med. 2004 Jul 29;351(5):438-50. doi: 10.1056/NEJMoa040842. N Engl J Med. 2004. PMID: 15282351 Clinical Trial.
Pharmacokinetics of ribavirin in patients with hepatitis C virus.
Wade JR, Snoeck E, Duff F, Lamb M, Jorga K. Wade JR, et al. Among authors: duff f. Br J Clin Pharmacol. 2006 Dec;62(6):710-4. doi: 10.1111/j.1365-2125.2006.02704.x. Br J Clin Pharmacol. 2006. PMID: 17118126 Free PMC article.
Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.
Snoeck E, Wade JR, Duff F, Lamb M, Jorga K. Snoeck E, et al. Among authors: duff f. Br J Clin Pharmacol. 2006 Dec;62(6):699-709. doi: 10.1111/j.1365-2125.2006.02741.x. Br J Clin Pharmacol. 2006. PMID: 17118125 Free PMC article.
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin.
Fried MW, Jensen DM, Rodriguez-Torres M, Nyberg LM, Di Bisceglie AM, Morgan TR, Pockros PJ, Lin A, Cupelli L, Duff F, Wang K, Nelson DR. Fried MW, et al. Among authors: duff f. Hepatology. 2008 Oct;48(4):1033-43. doi: 10.1002/hep.22448. Hepatology. 2008. PMID: 18697207 Clinical Trial.
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy.
Mauss S, Valenti W, DePamphilis J, Duff F, Cupelli L, Passe S, Solsky J, Torriani FJ, Dieterich D, Larrey D. Mauss S, et al. Among authors: duff f. AIDS. 2004 Sep 3;18(13):F21-5. doi: 10.1097/00002030-200409030-00002. AIDS. 2004. PMID: 15316334 Clinical Trial.
Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K. Grub S, et al. Among authors: duff f. Clin Pharmacol Ther. 2002 Mar;71(3):122-30. doi: 10.1067/mcp.2002.121423. Clin Pharmacol Ther. 2002. PMID: 11907486 Review.
Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.
Kline MW, Brundage RC, Fletcher CV, Schwarzwald H, Calles NR, Buss NE, Snell P, DeLora P, Eason M, Jorga K, Craig C, Duff F. Kline MW, et al. Among authors: duff f. Pediatr Infect Dis J. 2001 Jul;20(7):666-71. doi: 10.1097/00006454-200107000-00006. Pediatr Infect Dis J. 2001. PMID: 11465838
The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in Europe.
Moyle G, Pozniak A, Opravil M, Clumeck N, DelFraissy JF, Johnson M, Pelgrom J, Reynes J, Vittecoq D, DeLora P, Salgo M, Duff F. Moyle G, et al. Among authors: duff f. J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):128-37. doi: 10.1097/00126334-200002010-00004. J Acquir Immune Defic Syndr. 2000. PMID: 10737427 Clinical Trial.
Protease inhibitors in HIV infection. Lipodystrophy may be a consequence of prolonged survival.
Buss N, Duff F. Buss N, et al. Among authors: duff f. BMJ. 1999 Jan 9;318(7176):122. BMJ. 1999. PMID: 9880292 Free PMC article. No abstract available.
Feedback